Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP785795.RAT85L0xudO5QeqoDBpaRyYpqkIQ6FItACZlq_tHf2cjo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP785795.RAT85L0xudO5QeqoDBpaRyYpqkIQ6FItACZlq_tHf2cjo130_assertion type Assertion NP785795.RAT85L0xudO5QeqoDBpaRyYpqkIQ6FItACZlq_tHf2cjo130_head.
- NP785795.RAT85L0xudO5QeqoDBpaRyYpqkIQ6FItACZlq_tHf2cjo130_assertion wasGeneratedBy ECO_0000203 NP785795.RAT85L0xudO5QeqoDBpaRyYpqkIQ6FItACZlq_tHf2cjo130_provenance.
- NP785795.RAT85L0xudO5QeqoDBpaRyYpqkIQ6FItACZlq_tHf2cjo130_assertion wasDerivedFrom befree-20140225 NP785795.RAT85L0xudO5QeqoDBpaRyYpqkIQ6FItACZlq_tHf2cjo130_provenance.
- NP785795.RAT85L0xudO5QeqoDBpaRyYpqkIQ6FItACZlq_tHf2cjo130_assertion SIO_000772 15910495 NP785795.RAT85L0xudO5QeqoDBpaRyYpqkIQ6FItACZlq_tHf2cjo130_provenance.
- NP785795.RAT85L0xudO5QeqoDBpaRyYpqkIQ6FItACZlq_tHf2cjo130_assertion evidence source_evidence_literature NP785795.RAT85L0xudO5QeqoDBpaRyYpqkIQ6FItACZlq_tHf2cjo130_provenance.
- NP785795.RAT85L0xudO5QeqoDBpaRyYpqkIQ6FItACZlq_tHf2cjo130_assertion description "[To investigate the role of MIF in chronic hepatitis B infection, we studied two groups of hepatitis B surface antigen positive patients: group 1 (immune tolerant, n = 16) and group 2 (immune clearance, n = 16).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP785795.RAT85L0xudO5QeqoDBpaRyYpqkIQ6FItACZlq_tHf2cjo130_provenance.